Lacoramide is a medical device for treating epilepsy and neuropathic pain.
Action: drugs for epilepsy and neuropathic pain.
Lacoamide is a new type of antiepileptic drug, a new type of n-methyl-d-aspartic acid (NMDA) receptor glycine site binding antagonist. NMDA receptor glycine site is a new type of functional amino acid, which is a new type of functional amino acid. It can selectively promote the sodium channel inactivation and slow adjustment collapse response mediated protein 22 (CRMP22), and CRMP22 may slow or even prevent seizures and relieve diabetic neuropathic pain.
No comments:
Post a Comment